Document is current
Any future updates will be listed below
-
Authors
Tanabe, Yuko
Ishikawa, Eri
Yamada, Tomoaki
Shime, Nobuaki
Maeda, Shoichi
-
Funding
Funding for this research was provided by:
Kaken Pharmaceutical (JP 23K09623)
Hiroshima University
- License Information
-
More Information
Article History
Received: 28 April 2024
Accepted: 1 August 2024
First Online: 19 August 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Japanese Society of Intensive Care Medicine Clinical Trial Group (control number: 0047) and the ethics committee of Keio University’s Graduate School of Health Management (approval number: 2022–12).
: Not applicable.
: Not applicable.
: The authors declare that there are no competing interests.
